Csl Ltd ( ($CSLLY) ) has released its Q2 earnings. Here is a breakdown of the information Csl Ltd presented to its investors.

There were positives and negatives in the company's first half performance. The post CSL shares push higher despite 'mixed ...

Today's Elliott Wave analysis provides an update on the Australian Stock Exchange (ASX) focusing on CSL LIMITED (CSL). There is significant upside potential in the third wave of ASX:CSL. This analysis ...

CSL Vifor Thank you for standing by and welcome to the CSL Limited Half Year Financial Results. All participants are in a listen-only mode. There will be a presentation followed by a question-and ...

CSL Limited (ASX:CSL) shareholders are probably feeling a little disappointed, since its shares fell 4.8% to AU$257 in the week after its latest half-year results. Revenues of US$8.5b were in line ...

CEO Paul McKenzie announced a reaffirmation of guidance for fiscal 2025, targeting NPATA growth of 10% to 13%. He highlighted strong results from CSL Behring and growth in CSL Vifor, while ...

These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?

Citi analyst Mathieu Chevrier maintained a Hold rating on Sonic Healthcare Limited (SHL – Research Report) today and set a price target of ...

“CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in ...

Investing.com-- Australian biopharmaceutical giant CSL Ltd (ASX: CSL) reported a rise in half-year net profit, driven ...

CSL Limited (ASX:CSL) shareholders are probably feeling a little disappointed, since its shares fell 4.8% to AU$257 in the ...